Your browser doesn't support javascript.
loading
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
Costa, Olivia S; Beyer-Westendorf, Jan; Ashton, Veronica; Milentijevic, Dejan; Moore, Kenneth Todd; Bunz, Thomas J; Coleman, Craig I.
  • Costa OS; Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, CT, 06269, USA.
  • Beyer-Westendorf J; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA.
  • Ashton V; Thrombosis Unit, University Hospital "Carl Gustav Carus", Technical University Dresden, Dresden, Germany.
  • Milentijevic D; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
  • Moore KT; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
  • Bunz TJ; Janssen Pharmaceuticals, Inc, Titusville, NJ, USA.
  • Coleman CI; New England Health Analytics, LLC, Granby, CT, USA.
J Thromb Thrombolysis ; 51(2): 349-358, 2021 Feb.
Article en En | MEDLINE | ID: mdl-32588288
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Warfarina / Tromboembolia Venosa / Inhibidores del Factor Xa / Rivaroxabán / Anticoagulantes / Obesidad Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Warfarina / Tromboembolia Venosa / Inhibidores del Factor Xa / Rivaroxabán / Anticoagulantes / Obesidad Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article